MO-PIERIANDX
2.3.2021 15:02:14 CET | Business Wire | Press release
PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforce the company’s position as the leading provider of clinical genomics solutions in the fight against cancer and hereditary disease. She will also head the company’s life sciences efforts, establishing key alliances with industry partners and biopharmaceutical companies that will ultimately provide broader access to genomic testing and precision medicine-based treatments for patients.
Ms. Mateo is an experienced executive with a history of building world-class teams, devising successful commercial strategies, and building partnerships within the diagnostics industry. Prior to joining PierianDx, she served as Head of Commercial Operations and later as VP, Head of Life Sciences at Tempus. She has also led commercial teams at NAVICAN, an Intermountain Healthcare Company, focused on precision medicine, and Genoptix, now a NeoGenomics company.
“We are thrilled to welcome Lindsay to PierianDx in this exciting time of the company’s evolution and growth,” says Mark McDonough, Chief Executive Officer, PierianDx. “Lindsay brings deep experience in cancer diagnostics and life sciences, and she has an excellent track record helping emerging companies scale. She will spearhead efforts to leverage our data assets and build out our commercial strategy in engaging with industry partners and the biopharma market segment as the company manifests its vision to democratize clinical genomics globally.”
About PierianDx
Founded in 2014 out of Washington University in St. Louis, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its industry-leading clinical genomics technologies, IVD-ready knowledgebase and reporting solution, and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx drives the adoption of genomics in clinical care and accelerates the fight against somatic cancer and hereditary diseases. For more information visit www.pieriandx.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005098/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
illumynt Launches Talorem®, Bringing Engineering Rigor to Smarter Technology Reuse6.10.2026 14:38:00 CEST | Press release
Proprietary technology platform delivers faster receiving, better asset intelligence, more accurate grading and higher recovery value. illumynt, a technology-driven lifecycle management company serving AI infrastructure, hyperscale, OEM and enterprise environments, today announced the launch of Talorem®, its proprietary technology platform designed to bring greater precision, intelligence and recovery value to the management of advanced computing assets. Talorem is illumynt’s proprietary technology platform for engineering-grade testing, refurbishment, recovery, grading and asset intelligence at scale. As the technology foundation behind illumynt’s advanced computing lifecycle operations, Talorem brings together OEM-grade testing and qualification, clean room component recovery, centralized grading infrastructure and analytics to create greater intelligence at every stage of the asset lifecycle-enabling faster processing, more accurate grading and higher recovery value. “Talorem repres
Corpay Cross-Border Extends Exclusive Partnership with WBSC6.10.2026 14:30:00 CEST | Press release
Corpay will continue to provide the World Baseball Softball Confederation access to innovative global payments and comprehensive currency risk management solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into a long-term agreement to extend their successful and exclusive collaboration as the Official Foreign Exchange (FX) Payments Provider of the World Baseball Softball Confederation (WBSC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261006279113/en/ Since 2022, Corpay Cross-Border has delivered a range of corporate foreign exchange payment solutions to the WBSC, the international governing body for Baseball/Softball. With this multi-year extension, the WBSC and their members around the globe will continue to benefit from Corpay’s comprehensive currency risk management solutions and award-winning global payments platform. “O
Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 20266.10.2026 14:00:00 CEST | Press release
Podium presentation by Co-Founder and Chief Research Officer Laura van ’t Veer introduces an AI-driven approach to MammaPrintTwo additional poster presentations from the FLEX Study Agendia, Inc., a leader in precision oncology for breast cancer, announced today that it will present new research during a podium presentation on the development of an artificial intelligence (AI)-driven digital pathology approach for MammaPrintⓇ at the European Society for Medical Oncology (ESMO) Congress 2026, which takes place October 23 to 27, 2026, in Madrid. The company will also present two additional posters at ESMO. AI-driven digital pathology approaches are rapidly developing to expand access to genomic testing globally. Agendia’s first presentation, submitted as a late-breaking abstract, focuses on the development and validation of an AI-driven MammaPrint approach based on the analysis of routine whole slide images of breast cancer tissue. The following are details of the late-breaking abstract t
ExaGrid Named Finalist for the MSP Channel Insights Awards 20266.10.2026 14:00:00 CEST | Press release
ExaGrid Nominated in 7 Categories for Industry Awards ExaGrid, the world’s largest independent backup storage vendor providing Tiered Backup Storage for the fastest backups and restores, largest scale-out system with deduplication, and the most comprehensive security and AI-Powered Retention Time-Lock for Ransomware Recovery, today announced that it has been nominated in seven categories for the annual MSP Channel Insights Awards. The MSP Channel Insights Awards celebrate innovation, expertise and success across the IT channel—recognizing the Managed Service Providers (MSPs), vendors, distributors, resellers and technology leaders driving customer outcomes and business growth. Voting to determine the winner in each category is underway now and closes on October 30, 2026. Winners of the MSP Channel Insights Awards will be announced on November 26, 2026, at an awards ceremony in London. The award categories that ExaGrid has been nominated for include: Vendor of the Year Vendor Channel Pr
IFF Identifies the Life-Stage Insights Shaping Dairy’s Future6.10.2026 13:00:00 CEST | Press release
IFF (NYSE: IFF)—a global leader in flavors, fragrances and health and biosciences, published its latest resource, Dear Dairy: The Life Stages Guide. This strategic guide reveals how manufacturers can unlock new opportunities by aligning dairy innovation with consumers' evolving needs throughout life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005026164/en/ “Dairy is one of the few categories that evolves alongside consumers throughout their lives,” said Rogerio de Almeida Prado, vice president of Global Dairy & BBC (Bakery, Bars and Confectionery) for IFF Taste. “Over time, expectations change. What builds trust in childhood may need to support identity, convenience or vitality later in life. The next wave of dairy innovation will be defined not by a single trend, ingredient or claim, but by an understanding of what consumers need at different times of their lives — and why.” Drawing on insights from Panoptic™, IFF's
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom